Deregulated PI3K signaling in tumor cells further establishes an immunosuppressive niche by inducing activation of pro-inflammatory mediators, including nitric oxide synthase and lipoxygenase, in the tumor microenvironment [132]. Here, PIK3CD is linked to neoplasm.